ホーム > 市場調査レポート > 医療機器

市場調査レポート

商品コード

1086016

ハイドロゲルベースのドラッグデリバリーシステム市場：由来別、デリバリー経路別、地域別：規模、シェア、見通し、機会分析（2022年～2030年）

Hydrogel-Based Drug Delivery System Market, by Source, by Route of Delivery, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: 2022年05月06日 | 発行: Coherent Market Insights

| ページ情報: 英文 206 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 707,130円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,099,980円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,571,400円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界のハイドロゲルベースのドラッグデリバリーシステム市場について調査し、市場の概要とともに、由来別、デリバリー経路別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

Hydrogels are referred as natural or synthetic polymer materials that exhibit very versatile physical and biological properties. These polymers were first used as biological materials in 1960. Based on the source, the hydrogel can be obtained from natural sources or are synthetic in origin. The natural hydrogel include silk fibroin, alginate, chitosan, collagen, and hyaluronic acid. However, these natural hydrogels have few limitations such as they involve batch-to-batch variation leading to inconsistency in the product. Hence, they are often combined with synthetic hydrogels for creating a composite polymer.

Hydrogels are often used as drug delivery systems owing to its high compatibility with living tissues and property to preserve embedded proteins. Hydrogel-based drug delivery system acts as controlled drug delivery systems for delivering a certain drug such as antibiotics for a predefined duration of time. The other applications of hydrogel in medical sciences include replacement, restoration of anatomic structures, filtering wastewater, making contact lenses, and as pH sensors among others.

Market Dynamics

The growing research and development activities for using hydrogel-based drug delivery system for treating various injuries such as spinal cord injuries are contributing to the growth of hydrogel-based drug delivery system market. For instance, in January 2021, University of Arkansas biomedical engineering researcher was awarded a grant of US$100,000 from the PhRMA Foundation, an organisation that offers research grants; for developing the hydrogel-based drug delivery method for treating spinal cord injuries. The process involves embedding the stem cells in the matrix hydrogels, which facilitates better cell survival and hence can perform regenerative action for a longer duration.

Key features of the study:

This report provides an in-depth analysis of the global hydrogel-based drug delivery system market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global hydrogel-based drug delivery system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies

Key companies covered as a part of this study include Johnson & Johnson, Bausch & Lomb, Ocular Therapeutix, Inc, Tolmar Pharmaceuticals, Inc., Ashland, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Micropore Technologies, Neurelis, Inc., and ProLynx Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global hydrogel-based drug delivery system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global hydrogel-based drug delivery system market

Detailed Segmentation:

Global Hydrogel-Based Drug Delivery System Market, By Source
- Natural
  - Synthetic
  - Hybrid
Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery
- Oral Cavity
- Subcutaneous
- Topical
- Others
Global Hydrogel-Based Drug Delivery System Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Johnson & Johnson**
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bausch & Lomb
- Ocular Therapeutix, Inc
- Tolmar Pharmaceuticals, Inc.
- Ashland
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Micropore Technologies
- Neurelis, Inc.
- ProLynx Inc

"" marked represents similar segmentation in other categories in the respective section.*

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Route of Delivery
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Key developments
Regulatory Scenario
Market Trends
New Product Launches
Acquisitions and Agreements
Brand Analysis
Regulatory Scenario
PORTER's Five Forces Analysis

4. Global Hydrogel-Based Drug Delivery System Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact on Healthcare
Impact on Hydrogel-based Drug Delivery System Manufacturing and Its Market Demand
COVID-19 Epidemiology

5. Global Hydrogel-Based Drug Delivery System Market, By Source, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Natural
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral Cavity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Hydrogel-Based Drug Delivery System Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2028
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Delivery, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Delivery, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Delivery, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Delivery, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Delivery, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Delivery, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Market Share Analysis
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bausch & Lomb
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Ocular Therapeutix, Inc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Tolmar Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Ashland
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Pfizer, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Micropore Technologies
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Neurelis, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- ProLynx Inc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

9. Section

Research Methodology
About us

ライセンス / 価格

PDF (Single User License)

USD 4,500 707,130円

PDF (Multi User License)

USD 7,000 1,099,980円

PDF (Enterprise User License)

USD 10,000 1,571,400円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

当社から購入するメリット

よくあるご質問

ハイドロゲルベースのドラッグデリバリーシステム市場：由来別、デリバリー経路別、地域別：規模、シェア、見通し、機会分析（2022年～2030年）

Hydrogel-Based Drug Delivery System Market, by Source, by Route of Delivery, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学、規制、および動向分析

第4章世界のハイドロゲルベースのドラッグデリバリーシステム市場-COVID-19パンデミックの影響

第5章世界のハイドロゲルベースのドラッグデリバリーシステム市場：由来別、2017年～2030年、（100万米ドル）

第6章世界のハイドロゲルベースのドラッグデリバリーシステム市場：デリバリー経路別、2017年～2030年、（100万米ドル）

第7章世界のハイドロゲルベースのドラッグデリバリーシステム市場：地域別、2017年～2030年、（100万米ドル）

第8章競合情勢

第9章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

"" marked represents similar segmentation in other categories in the respective section.*

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Hydrogel-Based Drug Delivery System Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Hydrogel-Based Drug Delivery System Market, By Source, 2017 - 2030, (US$ Mn)

6. Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery, 2017 - 2030, (US$ Mn)

7. Global Hydrogel-Based Drug Delivery System Market, By Region, 2017 - 2030, (US$ Mn)

8. Competitive Landscape

9. Section

ハイドロゲルベースのドラッグデリバリーシステム市場：由来別、デリバリー経路別、地域別：規模、シェア、見通し、機会分析（2022年～2030年）

Hydrogel-Based Drug Delivery System Market, by Source, by Route of Delivery, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章 調査目的・前提条件

第2章 市場の展望

第3章 市場力学、規制、および動向分析

第4章 世界のハイドロゲルベースのドラッグデリバリーシステム市場-COVID-19パンデミックの影響

第5章 世界のハイドロゲルベースのドラッグデリバリーシステム市場：由来別、2017年～2030年、（100万米ドル）

第6章 世界のハイドロゲルベースのドラッグデリバリーシステム市場：デリバリー経路別、2017年～2030年、（100万米ドル）

第7章 世界のハイドロゲルベースのドラッグデリバリーシステム市場：地域別、2017年～2030年、（100万米ドル）

第8章 競合情勢

第9章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Hydrogel-Based Drug Delivery System Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Hydrogel-Based Drug Delivery System Market, By Source, 2017 - 2030, (US$ Mn)

6. Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery, 2017 - 2030, (US$ Mn)

7. Global Hydrogel-Based Drug Delivery System Market, By Region, 2017 - 2030, (US$ Mn)

8. Competitive Landscape

9. Section

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学、規制、および動向分析

第4章世界のハイドロゲルベースのドラッグデリバリーシステム市場-COVID-19パンデミックの影響

第5章世界のハイドロゲルベースのドラッグデリバリーシステム市場：由来別、2017年～2030年、（100万米ドル）

第6章世界のハイドロゲルベースのドラッグデリバリーシステム市場：デリバリー経路別、2017年～2030年、（100万米ドル）

第7章世界のハイドロゲルベースのドラッグデリバリーシステム市場：地域別、2017年～2030年、（100万米ドル）

第8章競合情勢

第9章セクション

"" marked represents similar segmentation in other categories in the respective section.*